Biomedical Engineering

2021-02-05 18:59:00

Design and applications of medical instrumentation for telemedicine

Medical instruments used in telemedicine is known as Point-of-Care (PoC) devices. These are the portable or wearable devices that can be used by anyone, at anytime and anywhere, at home or on the move, to measure vital signs of the users. The measured data are automatically sent to the cell phones of the users, his/her family doctors and relatives. If the data are out of normal ranges, the PoC device will alarm those caretakers to assist the users immediately as if they were next to each other. The design of those PoC devices includes traditional and emerging technologies such as: Electronics, Mechanics, Informatics, Internet of Things, Cloud computing and Artificial Intelligence. Their applications cover a wide range of fields including family medicine,  community health, and other medical and pharmaceutical specialties for treatment from distance, prevention and follow-up the chronical diseases. They are useful for general practitioners, specialists and researchers in clinics. If successful, those devices can be put on the market. We have developed a series of PoC devices. A wide range of research topics can be initiated based on clinical needs. Medical/pharmaceutical practitioners and students are cordially invited to discuss your ideas with the members of the BME Department.

Neuroscience, Engineering and Technology In Clinics (NETIC)

NETIC aims to elucidate genetic, neural, and behavioral mechanisms of neurodegeneration and to develop effective intervention and prevention strategies targeting these mechanisms to addressing the unmet needs of patients. In this regard, we are focusing on integrating neural technologies and theoretical neuroscience to effectively modulate central nervous system function through its designing, validating, and translating to clinic technology.

Precision medicine technology for cancer prognostics and treatments

The cancer survival rate can be improved by early detection, accurate diagnosis, and effective treatment. Still, no cancer treatment has 100% effective because of heterogeneity and drug resistance in cancer cells. The side effect of a cancer drug is also one of the major obstacles. However, its molecular regulation in therapeutic involvement is still unclear. The precision medicine approach which goal is to target the right treatments to the right patients at the right time is arising to overcome the limitations of traditional medicine. Precision medicine tailors to the genetic changes in each person’s cancer to help decide which treatment will work best for the patient. We focus on uncovering the new target for drug discovery to improve the effectiveness of cancer treatment.  Also, we identify the better tool to detect cancer in an early stage, guide diagnosis and treatment of cancer by understanding insight into the heterogeneity of cancer in both genetic and epigenetic aspects.

NMH.